Metro-MN Community Oncology Research Consortium

Minneapolis, Minnesota 55416

We've found

1 trials

at this facility

Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC

Status: Enrolling, Phase II
Updated: 4/11/2018

from

Minneapolis, MN

Use our guide to learn which trials are right for you!